胃癌患者外周血CEA,CK20 mRNA及VEGF的检测及意义
出处
《潍坊医学院学报》
2006年第1期51-53,共3页
Acta Academiae Medicinae Weifang
参考文献19
-
1Nishida S Kitamura K, Ichikawa D, et al. Molecular detection of disseminated cancer cells in the peripheral blood of patients weth gastric cancer[J]. Anticuncer Res ,2000,20(3B):2 225-2 226.
-
2Pectasides D, Mylonakis A, Kostopoulon. M, et al. CEA, CA19-9 and CA50 in monitoring gastric cacinoma[J]. Ant J Cin Oncol, 1997,20(3): 348-353.
-
3MarrelliD, Roviello F, De Stetano A, et al. Prognostic signification of CEA,CA19-9 and CA72-4 preoperative serum levels in gastric carcinoma[J].Oncology, 1999,57(5):55-62.
-
4Moi M, Minorik, Ueo Hm, et al. Molecill detection of circulating solid carcinoma cells in the peripheral blood the concept of early susremil disease[J]. Int J cancer, 1996,68(6):739-740.
-
5Oyama K, Terashima M, Takagane A, et al. Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription-polymerase chain reaction [J]. Br J Surg, 2004, 91(4): 435-443.
-
6Mori M, Mimori K, Ueo H, et al. Clinical significance of mlecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas[J]. J Clin Oncol, 1998,15(l):128-132.
-
7Gerhard M, Juhl H, Kalthoff H, et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction[J]. J Clin Oneol, 1994,12(4):725-729.
-
8Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type 1 cytokeratin with unusual properties and expression patterns[J]. J Cell Biol, 1990,111(2):567-580.
-
9Barchill SA, Bradbury MF, Pitlman K, et al. Dectection of epithelial cancer cells in peripheral blood bu reverse transcriptase-polymorase chail reaction[J]. Br J Career, 1995,71 (2):278-281.
-
10陈国裕,陈锡美,王志荣,朱风尚,王晓蕾,张霞.胃癌患者外周血细胞角蛋白20mRNA的检测及临床意义[J].同济大学学报(医学版),2003,24(5):403-405. 被引量:2
二级参考文献46
-
1[1]Wartiovaara U, Salven P, Mikkola H,et al. Peripheral blood platelets express VEGF C and VEGF which are released during platelet activation[J].Thromb Haemost,1998, 80(7): 171-173.
-
2[2]Shinichi K,Asano M,Matsuo K,et al. Vascular endothelial growth factor/ vascular permeability factor is detectable in the sera of tumor bearing mice and cancer patients[J]. Biochemica Biophysica Acta, 1994, 1221:211.
-
3[3]Obermair A, Tempfer C, Hefler L,et al. Concentration of vascular endothelial growth factor(VEGF) in the serum of patients with suspected ovarian cancer[J]. Br J Cancer, 1998, 77(11):1870-1874.
-
4[4]Miyake H, Hara I, Yamanaka K,et al. Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer[J]. Urology, 1999, 53(2): 302-307.
-
5[5]Tian X, Song S, Wu J,et al. Vascular endothelial growth factor acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803[J]. Biochem Biophys Res Commun, 2001, 286(3):505-512.
-
6[6]Yamamoto S, Konishi I, Mandai M,et al. Expression of vascular endothelial growth factor(VEGF) in epithelial ovarian neoplasms[J]. Br J Cancer,1997, 76(9):1221-1227.
-
7[7]Chin KF, Greeman J, Gardiner E,et al. Pre operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer[J]. Br J Cancer, 2000, 83(11):1425-1431.
-
8[8]Shimada H, Takeada A, Nabeya Y, et al. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma[J]. Cancer, 2001, 92(3): 663-669.
-
9[9]Salven P, Ruotsalainen T, Mattson K,et al. High pretreatment serum level of vascular endothelial growth factor(VEGF) is associated with poor outcome in small cell lung cancer[J]. Int J Cancer,1998, 79:144-146.
-
10Raj G, Moreno J, Cornelia L. Utilization of polymerase chain reaction technology in the detection of solid tumors [J]. Cancer, 1998,82(8) : 1419 - 1442.
共引文献26
-
1苏琪,韩霞,殷红专.CK20诊断大肠癌微转移的价值[J].世界华人消化杂志,2004,12(9):2153-2155. 被引量:3
-
2张秋宁,马力.三叶因子3在胃癌组织中的表达及与血管形成的关系[J].现代肿瘤医学,2005,13(1):42-44. 被引量:11
-
3程胜平,刘南植,钱颉.大肠腺瘤及癌组织HIF-1α的表达与凋亡增生的关系[J].世界华人消化杂志,2004,12(12):2792-2796.
-
4陈坚,林庚金,程建,唐峰,朱虹光,刘珊林.锰型超氧化物岐化酶基因转染抑制SGC7901胃癌细胞增殖的机制[J].世界华人消化杂志,2005,13(12):1386-1389. 被引量:7
-
5楼兰英.磁富集法检测52例胸腹腔积液中癌细胞的结果分析[J].实用癌症杂志,2005,20(5):495-497.
-
6顾永平,谢芳.胰腺癌组织中HIF-1α和VEGF的表达及临床意义[J].江苏医药,2006,32(4):385-386. 被引量:6
-
7李世栋,李珊珊,孙洋,卢创新,阎爱华.食管癌组织中缺氧诱导因子-1α蛋白的表达[J].郑州大学学报(医学版),2006,41(3):568-569. 被引量:3
-
8李辉.食管癌骨髓微转移分子检测的研究现状[J].中华外科杂志,2006,44(14):995-996. 被引量:5
-
9王景美,杜艳,郭英,吴平平,金月玲,田小强,黄培林.食管癌患者外周血CK20、CK19、CEA mRNA的表达及其临床病理意义[J].东南大学学报(医学版),2006,25(6):414-418. 被引量:11
-
10顾永平,谢芳,何杨,杨波.胰腺癌细胞在低氧状态中HIF-1、VEGF蛋白的表达及可溶性VEGF水平变化的生物学意义[J].中国现代医药杂志,2006,8(11):1-3. 被引量:1
-
1刘屹立,高同才,梁伟.CT在膀胱肿瘤常规检查中的应用价值[J].中国医科大学学报,1998,27(4):430-431.
-
2王军里,杨敏良.高频超声对临床难以触及的乳腺肿块的诊断价值[J].实用医技杂志,2008,15(8):992-993.
-
3戴伟英,陈阿琼,马星卫,刘黔霖.介入治疗绒癌Ⅲb期保留生育功能1例[J].贵阳医学院学报,2003,28(3):278-279.
-
4蒙岭,王勇.大肠癌肝转移27例外科治疗分析[J].临床医药实践,2003,12(5):390-390.
-
5王连祥,王春生.恶性淋巴瘤15例误诊分析[J].中国基层医药,2002,9(1):50-50.
-
6杨大兴.胃恶性淋巴瘤的X线误诊分析[J].中国冶金工业医学杂志,2003,20(6):473-474.
-
7孙海涛,于汀,张艺,赵大勇,杨秀娟.胃肠道间质瘤临床病理免疫组化临床研究[J].航空航天医学杂志,2012,23(6):658-659. 被引量:2
-
8边朝辉,王振中,郭艾,李亚东.肾透明细胞癌多发皮肤转移1例并文献复习[J].中国临床医生杂志,2017,45(3):115-116. 被引量:1
-
9Witte MH,邓列华,邓华峰.Kaposi肉瘤[J].国外医学(皮肤性病学分册),1991,17(2):91-94. 被引量:2
-
10杨渭临,张维信,袁天龙.血管造影对CT表现不典型性脑膜瘤的诊断价值[J].现代肿瘤医学,1995,3(4):217-218.